Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)

NCT00918489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Vorinostat

Sponsor

Heidelberg University

Collaborators

[object Object]